Tata Chemicals Limited · NSE:TATACHEM
Tata Chemicals — Q3 FY2019 Earnings Presentation
18 slides from Tata Chemicals's earnings presentation, Feb 5, 2019
Slide 1: Investors & Analyst Communication on Financial Results
Investors & Analyst Communication on Financial Results Q3 & 9M ending 31 December 2018 Dated: : 5 February 2019 1
Slide 2: Safe Harbour Statement
Safe Harbour Statement “This Presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expression
Slide 3: Key Highlights
Key Highlights Revenue from Operation − Consolidated at Rs 2,832 Cr (↑ by 10% vs. PY) − Standalone at Rs 1,019 Cr (↑ by 12% vs. PY) Profit Before Tax, Exceptional items and Share of Profit from JV and Associate − Consolidated at Rs 326 Cr (↓ by 10% vs. PY) − Standalone at Rs 189 Cr (↑ by 1% vs. PY)
Slide 4: Consolidated Performance: Q3 Dec FY2019
Financial Performance: 3 months ended Dec18 (Q3 Dec - FY2019) Continuing Operations Only 600 22% 600 21% 500 563 17% 500 545 400 471 400 Consolidated 300 300 2,832 8% 200 200 219 2,574 100 100 - - Q3 Dec 17 Q3 Dec 18 Q3 Dec 17 Q3 Dec 18 Q3 Dec 17 Q3 Dec 18 Revenue EBITDA PAT 250 180 25% 22% 160 17%
Slide 5: Consolidated Performance: YTD Dec FY2019
Financial Performance: 9 months ended Dec18 (YTD Dec - FY2019) Continuing Operations Only 1,800 22% 1,200 1,600 18% 1,678 1,000 13% 1,400 1,564 976 9% 1,200 800 Consolidated 1,000 755 8,537 600 800 600 400 400 7,790 200 200 - - YTD Dec 17 YTD Dec 18 YTD Dec 17 YTD Dec 18 YTD Dec 17 YTD Dec 18 Revenu
Slide 6: Financial Performance: PBT – Reconciliation
Financial Performance: PBT – Reconciliation Q3 Dec 18 – Rs Cr • TCNA: Lower Production & impact of power outage (Rs 22 Cr), lower average selling price 20 36 (Rs 22 Cr) and additional energy cost (Rs 8 Cr). 11 13 362 Sales and Production volumes where higher vs. 32 10 8 326 Q2. • TCE: Adverse Salt s
Slide 7: Financial Performance: PBT before share of Profit / Loss from JVs
Financial Performance: PBT before share of Profit / Loss from JVs Standalone Consolidated Continuing Discontinued Continuing Exceptional items Discontinued 1,600 1,033 926 400 400 1,152 60 473 937 707 286 1,140 1,191 286 632 189 298 60 - - 187 189 362 326 (11) (28) (28) (11) Q3 PY Q3 CY YTD PY YTD C
Slide 8: Financial Performance: PAT – Reconciliation
Financial Performance: PAT – Reconciliation Rs Cr Q3 FY18 Q3 FY19 YTD FY18 YTD FY19 Reported PAT 831.6 266.3 1,492.3 936.8 PAT from Discontinued Operation 213.6 - 288.2 (8.0) Deferred Tax Credit in TCNA 246.6 - 246.6 - Exceptional (Loss) / Gain - - - - US actuarial gain on amendment in medical benef
Slide 9: Performance: Segment Information (Q3 Dec FY2019)
Financial Performance: Segment Information (Q3 Dec - FY2019) Consolidated Standalone *Excludes Inter Segment Revenue of Rs 212 Cr (PY Rs. 182 Cr) & *Excludes Inter Segment Revenue of Rs 209 Cr (PY Rs. 180 Cr) & Unallocated Revenue of Rs 2 Cr (PY Rs 4 Cr) Unallocated Revenue of Rs (1) Cr (PY Rs 4 Cr)
Slide 10: Financial Update: Borrowing position
Financial Update: Borrowing position Debt Waterfall chart – Consolidated Debt Waterfall chart – Standalone 7,000 5,000 584 4,000 6,000 316 3,000 5,000 3,237 2,000 4,000 4,047 1,000 773 1,407 82 6,418 3,000 6,150 716 - 2,000 -1,000 -2,521 1,000 2,103 -2,000 -3,000 - Gross Debt Net Change Revaluation
Slide 11: Business Updates: Basic Chemistry Products
Business Updates: Basic Chemistry Products Q3 Segment Revenue & Results • Revenue from India business was at Rs 746 Cr (up by 10%), on account of higher sales realization, partly offset by lower sales volumes by 10 Kts. Margins was at Rs 183 Cr (down by 6%), mainly due to higher 2,142 1,951 power /
Slide 12: Business Updates: Consumer Products
Business Updates: Consumer Products Q3 Segment Revenue & Results • Salt business remained stable, with TATA Salt continues to perform well with Market Share of ~25% of the overall salt industry. 471 • Revenue from consumer products business stood at Rs 471 Cr ( up by 403 17%) with improved sales vol
Slide 13: Business Updates: Specialty Products
Business Updates: Specialty Products Q3 Segment Revenue & Results • Revenue from overall specialty products business stood at Rs 429 Cr ( up by 8%). 429 • Rallis India revenue stood at Rs 417 Cr ( up by 7%), due to higher sales 397 realization in international market and improved sale in Metahelix w
Slide 14: Business Updates: Subsidiary Financials
Business Updates: Subsidiary Financials Q3 Dec – FY2019 Units TCL India US UK Africa Rallis Consolidated* Rs Cr PY CY PY CY PY CY PY CY PY CY PY CY Revenue 912 1,019 787 889 375 371 117 144 389 417 2,574 2,832 EBITDA 228 224 180 171 63 14 20 29 38 28 563 471 PBT 187 189 100 80 25 (7) 8 19 28 20 362
Slide 15: Key Products: Production & Sales
Key Products: Production & Sales Soda Ash Quantity (In Kts.) Sodium Bicarbonate Quantity (In Kts.) Branded Salt Quantity (In Kts) TCL India TCE TCML TCNA TCL India TCE Q3 Dec - FY2019 29 27 30 28 562 571 593 566 279 280 78 80 82 78 267 104 83 92 85 27 24 28 28 258 182 172 205 203 82 79 79 82 1,761 1
Slide 16: Awards, Recognitions and Customer connect
Awards, Recognitions and Customer connect Awards & Recognitions Customer Connect Utsav Exhibition, Pune (Oct’18) 16
Slide 17: Other Financials Highlights
Other Financials Highlights Trailing Quarters – Consolidated Revenue (Rs Cr) & PAT* Margin (%) Earnings Per Share (Consolidated) 14% 10% 10% 12% 14% 2,961 12.6 2,744 2,832 12.0 2,574 2,555 9.4 9.7 8.4 Q3 FY18 Q4 FY18 Q1 FY19 Q2 FY19 Q3 FY19 Q2 FY18 Q3 FY18 Q4 FY18 Q1 FY19 Q2 FY19 Shareholding Patter
Slide 18: Tata Chemicals
TATA CHEMICALS Transform Grow For any question/queries please contact & John Mulhall & jmulhall@tatachemicals.com & Sameer Kulkarni & sakulkarni@tatachemicals.com & Gavin Desa & gavin@cdr-india.com & Suraj Digawalekar & suraj@cdr-india.com ® +91 22 6665 8282 ® +91 22 6665 7942 ® +91 226645 1237 © +9